April 24, 2026 GLOW photoaging research covering UV induced skin damage, matrix metalloproteinase modulation, collagen preservation, and antioxidant defense in photoaging models
DAS28 disease activity scores improved within the diet group from 5.2 to 4.2, though the difference between groups was not statistically significant
And the fact that Lilly has already flagged this as a Phase 3 initiation planned for 2026, rather than leaving it in Phase 2 exploration, suggests internal data they have not yet published
Specifically, the VAS statements were: (a) good effects: At this moment, are you experiencing good effects from the drink
All research materials are sealed for integrity and packaged for stability during storage and transport from manufacturing through final delivery.